US Patent Issued to CureVac on Jan. 20 for "Artificial RNA molecules encoding a norovirus antigen and uses thereof" (German Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,856, issued on Jan. 20, was assigned to CureVac SE (Tubingen, Germany).

"Artificial RNA molecules encoding a norovirus antigen and uses thereof" was invented by Susanne Rauch (Tubingen, Germany), Kim Ellen Schwendt (Dettenhausen, Germany) and Benjamin Petsch (Tubingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to an artificial nucleic acid and to polypeptides suitable for use in treatment or prophylaxis of an infection with Norovirus or a disorder related to such an infection. In particular, the present invention concerns a Norovirus vaccine. The present invention is directed to an artificial nucleic ac...